PMC-401s

N/A

Report date: 2024/01/09 11:11:23

Base Information

Drug NamePMC-401s

Drug Alias NameAnti-ANG2 antagonistic fully human ScFv (PharmAbcine)PMC-401s

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)

Mechanisms of ActionAnti-Angiopoietin-2

TargetsAngiopoietin-2

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPharmabcine

China Registration ClassN/A

Active CompaniesPharmabcine

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A